CREDIT SUISSE AG/ - RELMADA THERAPEUTICS INC ownership

RELMADA THERAPEUTICS INC's ticker is RLMD and the CUSIP is 75955J402. A total of 98 filers reported holding RELMADA THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.42 and the average weighting 0.3%.

Quarter-by-quarter ownership
CREDIT SUISSE AG/ ownership history of RELMADA THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$3
-100.0%
1
-100.0%
0.00%
-100.0%
Q3 2022$617,000
+81.5%
16,680
-6.9%
0.00%
Q2 2022$340,000
-28.9%
17,922
+1.3%
0.00%
Q1 2022$478,000
+94.3%
17,696
+62.2%
0.00%
Q4 2021$246,000
+6.5%
10,907
+51.0%
0.00%
Q2 2021$231,000
-9.1%
7,223
+0.3%
0.00%
Q1 2021$254,000
-33.7%
7,204
-39.8%
0.00%
Q4 2020$383,000
+71.0%
11,975
+100.8%
0.00%
Q3 2020$224,000
-36.9%
5,963
-25.0%
0.00%
Q2 2020$355,0007,9470.00%
Other shareholders
RELMADA THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Deep Track Capital, LP 2,837,818$9,903,9850.42%
Sio Capital Management, LLC 235,500$821,8950.30%
Sio Capital Management, LLC 235,600$822,2440.30%
apricus wealth, LLC 77,329$269,8780.25%
RTW INVESTMENTS, LP 2,067,824$7,216,7060.15%
PARSONS CAPITAL MANAGEMENT INC/RI 496,254$1,731,9260.14%
Aristides Capital LLC 69,322$241,9340.12%
XTX Topco Ltd 129,387$451,5610.10%
AdvisorShares Investments LLC 81,362$283,9530.08%
Ikarian Capital, LLC 65,491$228,5630.06%
View complete list of RELMADA THERAPEUTICS INC shareholders